The effectivity of selected antibiotics on strains of staphylococci isolated from normal lids by Boychuk, Catherine K
Pacific University 
CommonKnowledge 
College of Optometry Theses, Dissertations and Capstone Projects 
4-1995 
The effectivity of selected antibiotics on strains of staphylococci 
isolated from normal lids 
Catherine K. Boychuk 
Pacific University 
Recommended Citation 
Boychuk, Catherine K., "The effectivity of selected antibiotics on strains of staphylococci isolated from 
normal lids" (1995). College of Optometry. 1112. 
https://commons.pacificu.edu/opt/1112 
This Thesis is brought to you for free and open access by the Theses, Dissertations and Capstone Projects at 
CommonKnowledge. It has been accepted for inclusion in College of Optometry by an authorized administrator of 
CommonKnowledge. For more information, please contact CommonKnowledge@pacificu.edu. 
The effectivity of selected antibiotics on strains of staphylococci isolated from 
normal lids 
Abstract 
Staphylococcal diseases are commonly diagnosed in the optometric office. The normal healthy eye 
contains approximately two to three strains of various staphylococcal species, and these indigenous 
staphylococci are thought to be able to infect ocular tissues and cause ocular disease. Many strains of 
staphylococci are becoming resistant or are resistant to the antibiotics that are used to treat eye 
diseases. Data which present the variation of antibiotic susceptibility will assist the prescription choice 
and prognosis the optometrist selects for the infected patient. Forty subjects free of clinical eye disease 
were selected from students at PUCO. Cultures were taken from their eyelid margins and the bacteria 
were identified using standard techniques. Fifty-nine isolates were Staphylococcus epidermidis and one 
isolate was Staphylococcus au reus. Susceptibility to 1 0 antibiotics was determined for all 60 isolates 
using the disk diffusion test. The number of isolates susceptible to the antibiotics ranged from 98% for 
cefazolin to 59% for bacitracin. 
Degree Type 
Thesis 
Degree Name 
Master of Science in Vision Science 
Committee Chair 
Dr. Diane Yolton 
Subject Categories 
Optometry 
This thesis is available at CommonKnowledge: https://commons.pacificu.edu/opt/1112 
Copyright and terms of use 
If you have downloaded this document directly from the web or from CommonKnowledge, see 
the “Rights” section on the previous page for the terms of use. 
If you have received this document through an interlibrary loan/document delivery service, the 
following terms of use apply: 
Copyright in this work is held by the author(s). You may download or print any portion of this 
document for personal use only, or for any use that is allowed by fair use (Title 17, §107 U.S.C.). 
Except for personal or fair use, you or your borrowing library may not reproduce, remix, 
republish, post, transmit, or distribute this document, or any portion thereof, without the 
permission of the copyright owner. [Note: If this document is licensed under a Creative 
Commons license (see “Rights” on the previous page) which allows broader usage rights, your 
use is governed by the terms of that license.] 
Inquiries regarding further use of these materials should be addressed to: CommonKnowledge 
Rights, Pacific University Library, 2043 College Way, Forest Grove, OR 97116, (503) 352-7209. 
Email inquiries may be directed to:.copyright@pacificu.edu 
The Effectivity of Selected 
Antibiotics on Strains of 
Staphylococci Isolated From 
Normal Lids 
By 
Catherine K. Boychuk 
A thesis submitted to the faculty of the 
College of Optometry 
Pacific University 
Forest Grove, Oregon 
for the degree of 
Doctor of Optometry 
April, 1995 
ADVISER: 
DR. Diane Yolton,Ph.D., O.D. 
Signature Page 
AUTHOR: 
/.. 
7 /'?~ 
_ .. .diec!_~_c;{};=fo~~£,_ ______ _ 
Catherine K. Boycliuk, 4TH ~EAR STUDENT 
FACUL TV ADVISER: 
/)~ V4~ 
Dr. Diane Yolton,P~-6:D. 
ABOUT THE AUTHOR 
Catherine graduated from the University of Alberta in 1991 with a B.Sc. 
concentrating in microbiology. During her years at the University of Alberta, 
Catherine taught ballet (Royal Academy as well as Cecchetti syllabus) and 
piano (Royal Conservatory). After graduation she worked in a medical 
laboratory and a home for the mentally & physically handicapped until 
' 
September of 1992, at which point she began optometry school at Pacific 
University. In May of 1995 she will receive a Doctor of Optometry degree from 
Pacific University, and will seek employment in a full scope optometric practice 
in western Canada. 
ABSTRACT 
Staphylococcal diseases are commonly diagnosed in the optometric 
office. The normal healthy eye contains approximately two to three strains of 
various staphylococcal species, and these indigenous staphylococci are 
thought to be able to infect ocular tissues and cause ocular disease. Many 
strains of staphylococci are becoming resistant or are resistant to the antibiotics 
that are used to treat eye diseases. Data which present the variation of antibiotic 
susceptibility will assist the prescription choice and prognosis the optometrist 
selects for the infected patient. 
Forty subjects free of clinical eye disease were selected from students at 
PUCO. Cultures were taken from their eyelid margins and the bacteria were 
identified using standard techniques. Fifty-nine isolates were Staphylococcus 
epidermidis and one isolate was Staphylococcus au reus. Susceptibility to 1 0 
antibiotics was determined for all 60 isolates using the disk diffusion test. The 
number of isolates susceptible to the antibiotics ranged from 98% for cefazolin 
to 59% for bacitracin. 
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INTRODUCTION 
Staphylococcus epidermidis and S. aureus are the most significant 
bacteria in the cause of ocular infections such as blepharitis, hordeoli, 
conjunctivitis, keratitis, pre-septal and orbital cellulitis, and endophthalmitis1•2•3• 
The lids and conjunctiva of normal healthy eyes harbor these same species of 
staphylococci and these indigenous staphylococci are thought to be able to 
infect ocular tissues and result in disease. The normal flora is a part of the 
ocu lar defense against infection by providing protection against colonization by 
organisms of greater virulence. However, this steady state can be disrupted by 
excess proliferation of the normal flora or invasion into the ocular tissue which 
will also result in infection4. 
A high degree of accuracy and efficiency is required in the identification 
of the infectious organism. In the laboratory this can be accomplished on the 
basis of colony morphology, Gram stain, susceptibility to novobiocin, catalase 
test, Schleifer & Kloos' test, and the coagulase test. In clinic this process in not 
feasible, and treatment of a patient may require an immediate prescription and 
application of an antibiotic. 
Therapeutic Pharmaceutical Agents (TPAs) legislation in numerous 
states and proceeding in some Canadian provinces, warrants the necessity for 
antibiot ic research pertaining to optometric concerns. There is insufficient 
information presently available which compares the effectivity of ocular 
antibiotics on staphylococci. Staphylococcal diseases are commonly 
diagnosed in the optometric office, therefore data which presents the variation 
of antibiotic susceptibility will assist the prescription choice and prognosis the 
optometrist selects for the infected patient. 
Various strains of staphylococci manifest resistance to antibiotics; 
therefore these ineffective antibiotics need to be identified5. Also, because of 
these resistant disease-producing bacteria, more new and effective microbial 
agents need to be continually discovered and developed. A number of topical 
ophthalmic agents are available for clinical use. Nevertheless, there is 
considerable variation in the properties of these drugs, such as there 
antibacterial activity and effectiveness. This project was designed to determine 
the SU$Ceptibility of commonly used ophthalmic antibiotics against strains of 
Staphylococcus epidermidis isolated from eyes free of ocular disease. 
MATERIALS AND METHODS 
Forty subjects were solicited from the optometry students at Pacific 
University College of Optometry. The ocular surfaces were determined to be 
free of clinical disease with a biomicroscope. A sterile cotton swab was 
moistened with sterile spray saline and the right lower eyelid margin was 
swabbed once in one direction6 • Half of a petri dish with a non-selective solid 
medium (tryptic soy agar) was then inoculated. A new swab was moistened 
and the left lower lid margin was swabbed and the other half of the petri dish 
inoculated. The plates were incubated for 24 hours at 35C. 
From each plate with growth, isolated colonies were selected. At least 
one colony was selected from each lid margin. If any colonies with different 
morphology were present, these would represent different strains of 
staphylococci and therefore would also be selected for isolation7. The streak 
dilution technique was then used to re-isolate individual colonies on tryptic soy 
agar (TSA). As a result, there was a minimum of two bacterial isolates per 
subject 
Several tests were performed to identify the bacterial isolates. A sample 
of each isolate was Gram-stained to determine the Gram characteristic and the 
shape and arrangement of cells. 
Staphylococci produce the enzyme catalase (catalase positive), which 
differentiates this genus from the streptococci genus (also Gram positive cocci). 
An isolated colony was removed from the TSA plate with a sterile loop and 
added to a drop of 3% H20 2 on a microscope slide6.s. The continued 
appearance of gas bubbles indicated a positive test for the detection of the 
enzyme catalase. 
Free coagulase, which causes plasma to clot, is an extra cellular enzyme 
produced by the S. aureus strains but not S. epidermidis strains. The tube 
coagulase test was performed by inoculating 0.5mL of plasma with a loop of 
each isolate as well as the S. aureus control. The vials were then incubated for 
4 hours at 35C and coagulation was determined9 • 
S. saprophyticus and many micrococci are resistant to low 
concentrations of novobiocin whereas S. aureus and S. epidermidis are 
susceptible9 . A TSA plate was inoculated with each isolate and a 5ug 
novobiocin disk was placed on the surface. The plate was incubated for 24 
hours. Those plates that presented with zones of inhibition were indicative of S. 
aureus or S. epidermidis. 
Schleifer and Kloos' test was used to determine if any isolate was a 
micrococcus instead of a staphylococcus. Plates of purple agar base with the 
addition of 1 Omi/L and 0.4 mg/L of erythromycin were prepared1o. This media 
identifies staphylococci versus micrococci due to the change in color of the 
indicator (bromocresol purple) to yellow by staphylococci and no growth nor 
color change by micrococci9 •11. Table 1 summarizes the process of 
identification and differentiation of the isolates. 
S. aureus 
Colony Irregular 
Morphology clusters 
Gram stain + 
Novobiocin susceptible 
Catalase + 
Coagulase + 
Schleifer & + 
Kloos' Test 
Table 1. 
Tests for the Differentiation 
of 
Various Microorganisms 
S. epidermidis S. saprophyticus 
Irregular Irregular 
clusters clusters 
+ + 
susceptible resistant 
+ + 
-
+ + 
Micrococcus Streptococci 
Irregular Diplococcus 
clusters or chains 
+ + 
-
-
The most frequently used laboratory procedure to assess the in vitro 
effectivity of antimicrobial agents is the disk diffusion method. This simple 
procedure provides accurate and reproducible results from FDA standardized 
antibiotic disks12. An isolated colony was removed from a TSA plate and 
inoculated into a tube of TSB (tryptic soy broth). The TSB was incubated for 4-8 
hours until the turbidity was equal to the McFarland Turbity Standard. Mueller 
Hinton Agar plates were then swabbed so that the entire surface was uniformly 
covered. The antibiotic disks were gently yet securely placed on the moist agar 
surface with a disk dispenser. Only five disks were placed on each plate to 
allow for sufficient antibiotic diffusion into the medium. A total of 10 antibiotics 
were tested per isolate. After a 16-18 hour incubation period, the zones of 
inhibition were measured to the nearest millimeter. The results were compared 
to the zone diameter interpretive standards which are regulated by the FDA 
(Table 2)13·14. 
The disk diffusion method of antibiotic susceptibility testing must be 
performed in a standardized manner in order to minimize errors. Mueller Hinton 
Agar can vary between manufacturers in the concentration of calcium and 
magnesium, therefore affecting consistency with laboratory testing. We chose 
to use DIFCO laboratories for all our supplies. 
The commercially available antibiotic disks are a reliable product due to 
control by the FDA. As long as the disks are stored at temperatures lower than 
8C, used before the expiration date, and spaced uniformly from each other, then 
error due to the disks are unlikely13. To assure ourselves of standardized 
procedure, the disks were allowed to equilibrate to room temperature (to 
minimize the amount of condensation) and equally spaced on the media with 
the use of a disk dispenser {5 disks/plate). 
Table 2. 
Zone Diameter Interpretive Standards 
Antimicrobial Disk Content Zone Diameter 
Resistant Intermediate Susceptible 
Cefazolin 30 ug ~14 15-17 ~18 
Ciprofloxacin 5ug ~15 16-20 ~21 
Vancomycin 30 ug ~9 10-11 ~12 
Tobramycin 10ug ~12 13-14 ~15 
Trimethoprim 5ug ~10 11-15 ~16 
Gentamicin 10ug ~12 13-14 ~15 
Sulfisoxazole 300ug ~12 13-16 ~17 
Tetracycline 30ug ~14 15-18 ~19 
Erythromycin 15ug ~13 14-22 >23 
Bacitracin 1 Ounits ~8 9-12 ~13 
The most significant effect on inhibitory zone size is variation in inoculum. 
The inoculum density was adjusted to approximately 108 CFU/ml using a 0.5 
MCFarland barium sulfate turbidity standard12. Slight variation may have 
occurred in the critical cell mass during the growth period. If the inocula was 
lower than average (1 o8 colony units/ml) false susceptible results could have 
occurred. 
Incubation may affect each plate, because the incubator temperature 
may not be uniform (equally distributed) throughout the entire chamber. The 
incubators we used were of sufficient size, therefore enabling the plates to be 
spaced evenly so that they all reached 35C at approximately the same time. 
Measurement of the inhibitory zone diameter was performed with a 
standard 15 em ruler and the unaided eye to determine the area of no growth. If 
the zones were not completely circumferential, the radius was measured and 
doubled to obtain the diameter of the zone. 
In order to eliminate excess surface moisture within the petri dishes, the 
plates that were removed from the refrigerator and placed in the incubator (35C) 
with the lids ajar. 
With each batch of samples, a Staphylococcus aureus (ATCC 25922) 
control was also involved in each testing procedure for the purpose of quality 
control. The flow chart titled Procedure for Isolation and Susceptibility Testing 
of Staphylococcus epidermidis indicates the methods used in this project. 
RESULTS 
Of the 80 specimens (40 subjects- 80 eyelid margins), 71 had colony 
growth. From these plates, 60 isolates were selected. (Several of the plates 
were unusable because the colonies ran together and isolated colonies were 
Subject•s Name . 
Incubate 24 h 
FBD 2 TSA 
/ 
Catalase 
ram 
Schleifer Stain 
& Kloos• 
(purple agar) 
24 h 
Novobiocin disc 
on TSA or MH 
24 h 
FBS 1 
FBS2 
Procedure for Isolation and 
Susceptibility Testing of 
Staphylococcus epidermidis 
Incubate 24 h 
-6 h 
compare to McFarland std. 
I 
Coagulase plasma 
tubes 
Mueller Hinton Agar 
with antibiotic discs 
24 h I 
Measure zones of 
inhibition 
not discernible.) The morphology of each isolate except one, was round, 
elevated, and porcelain white in color. The unique colony was also round and 
elevated, but it had a golden creamy color. 
After performing the gram stain, the observation through the microscope 
displayed uniform, gram positive cocci arranged in irregular clusters. These 
results were indicative of staphylococci and consistent for all sixty isolates. 
In order to rule out streptococci from the possible gram positive 
microorganisms, the catalase test was required. Every isolate responded with a 
catalase positive result, therefore verifying that there were no streptococci 
isolated from any of the healthy eyes. 
It was safe to conclude that S. saprophyticus did not exist in our pool of 
isolated microorganisms due to the fact that all the isolates showed 
susceptibility to the novobiocin disks. 
The Schleifer & Kloos' test assured us that micrococci were non-existent 
in all 60 isolates. Every plate of purple agar had changed from purple to yellow. 
The coagulase test was the last procedure which verified the isolation of 
Staphylococcus epidermidis from the healthy eyelid margin. Other than the 
control S. aureus, there was only one other isolate which resulted in a positive 
coagulase test. Therefore, fifty-nine of the sixty isolates were S. epidermidis 
and only one eyelid produced a S. aureus isolate. 
The percent of the isolates of S. epidermidis and S. aureus resistant and 
susceptible to each of the tested 10 antibiotics is shown on Table 3. For each 
antibiotic, some isolates were resistant and some were susceptible. However, 
the percent susceptibility ranged from 98% with cefazolin to 59% with 
bacitracin. 
Table 3. 
Percentage of the Isolates of 
Resistant/Susceptible to 
Cefazolin II 
Ciprofloxacin I 
Vancomycin I 
Tobramycin I 
Trimethoprim I 
I 
I 
I 
I 
Resistant 
1.85% 
1.92% 
0% 
3.4% 
7.5% 
Staphylococcus epidermidis 
the Selected Antibiotics 
Intermediate I Susceptible 
0% II 98.15% 
0% I 98.07% 
3.5% I 96.5% 
3.4% 93.1% 
3.8% 88.7% 
I 
I 
I 
Gentamicin I >=I !!!!!!!!!!!!!!!!!!!!!5!!!.!!!!!6!1!!%~-!!!!!!!f ~--7!!!.!!!4!!!%!!!!!!!!!!!!!!!!!!===11 >=I !!!!!!!!!!!!!!!!!!!!!8!!!7!!!.0!!!o/c!!!o --~ 
Sulfisoxazole II 20% 3.6% II 76.4% 
Tetracycline J I 12.5% I 12.5% I 75.0% 
Erythromycin I I 17.0% I 15.1% I 68.0% 
Bacitracin I ._1 ___ 5.;..._4.;..%;...... _ __.1 ,_1 __ ...;;3..;;.5_. 7...;;0/c..;.o __ _.l ,_1 __ ..;;.5..;.8...;;. 9....;.0/c.;;.o __ _. 
DISCUSSION 
The genus Staphylococcus contains 27 different species, most of which 
are coagulase-negative1s,16. Staphylococcus epidermidis, a coagulase-
negative staphylococcus, predominated among the indigenous flora isolated 
from the 40 healthy eyelid margins. 
S. epidermidis has not been considered as clinically significant as S. 
aureus, Streptococcus and Psuedomonas due to its relatively low virulence4• 
However, S. epidermidis has in recent years been considered more intrinsically 
virulent than previously thought. With its ubiquitous nature and minuscule 
nutritional requ irements, S. epidermidis can pose a significant clinical dilemma 
if it is the causal organism at the site of an infection17,1s. 
Another factor in its virulence, is the ability of coagulase-negative 
staphylococci, to adhere to and colon ize on smooth surfaces; especially 
polymers. This process involves nonspecific electrostatic and hydrophobic 
interactions. Biopolymers, wh ich comprise many medical /optometric devices, 
are highly hydrophobic19. As a result, microorganisms may be transferred from 
these devices directly to the ocular surfaces. 
A case study of a posterior chamber lens implant (polymer) resulted in 
severe endophthalmitis with the cultures yielding S. epidermidis. 
Staphylococcus epidermidis produces an extra cellular slime substance which 
protects the bacterial cells from the host's immune response20. 
The cond itions conducive for infection usually involve a breakdown of 
host defenses such as a corneal abrasion with infected material, extended wear 
contact lenses, and both local and systemic disorders. Not only will the 
invasion into the tissue cause infection, but also the excessive proliferation of 
the indigenous flora and its by-products can become toxic to the eye. 
If prevention of infection has not been successful, then the next 
question is to determine which antibiotic would be most effective against S. 
epidermidis. Resistance to a wide variety of antibiotics has developed rapidly 
among coagulase-negative staphylococci. The frequency of a spontaneous 
mutational event occurs in one cell out of 1 o4 to 1 oB cells on average. Despite 
this deceptively low probability, one must consider the number of bacteria 
generated per unit time (number of cells increase linearly with time i.e. 
logarithmic or exponential growth). Population densities of bacteria usually 
reach 109 to 1010 cells/ml within 24 hrs on an enriched mediume,21. This 
increases the chances of a mutation occurring. In addition, resistance to 
multiple unrelated antibiotics have emerged through a mechanism in the 
bacteria called plasmid-carried genes8 . Therefore, it is essential to monitor and 
update antibiotic effectivity. 
The pharmacological activity of antibiotics is most ·effective when the 
patient uses a sufficient quantity over a specific period of time. Unfortunately, 
cl inicians may not emphasize to patients the importance of the administrative 
procedure of the drug. As a result, infectious bacteria develop resistant strains 
to the antibiotic while the weaker bacteria may be destroyed during the time the 
antibiotic was used by the patient. Perhaps at some point in time science will 
decipher the microorganisms mechanisms for resistance and therefore able to 
design drugs which would be capable of attacking these resistant mechanisms. 
This study demonstrates that many strains of S. epidermidis are resistant 
to su lfisoxazole and tetracycline. This resistance is well known and often 
influences our choice of an antibiotic if we assume the infection could be 
caused by staphylococci22·5• However, erythromycin and bacitracin are often 
used to treat staphylococcal blepharitis and yet many strains of S. epidermidis 
were shown to be non-susceptible to these antibiotics23. Perhaps we need to 
reconsider the use of these antibiotics in staphylococcal infections24,2s. Or 
perhaps the concentration of antibiotic applied to the lid overcomes this lack of 
susceptibility. 
CONCLUSION 
Recent acknowledgment of S.epidermidis as a significant infectious 
microorganism stimulated the need to research the antibiotics which are 
effective against its proliferation. If S. epidermidis is identified as the organism 
of an ocular infection, then it would by clinically advisable to suggest the use of 
cefazolin or ciprofloxacin. With proper instructions and compliance in the 
administration of the drug, patients can aide the medical field in the fight of 
resistant strains of microorganisms. 
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